The primary purpose of the study is to determine if IVT injections of ANX007 every month reduce vision loss in participants with GA secondary to age-related macular degeneration (AMD).
Geographic Atrophy
The primary purpose of the study is to determine if IVT injections of ANX007 every month reduce vision loss in participants with GA secondary to age-related macular degeneration (AMD).
A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA)
-
Retina Macula Institute of Arizona, Scottsdale, Arizona, United States, 85255
Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States, 90211
RCOC Clinical Research Institute Inc, Fullerton, California, United States, 92835
Retina Consultants Medical Group, Modesto, California, United States, 95356
Northern California Retina Vitreous Associates Medical Group, Inc., Mountain View, California, United States, 94040
Retina Consultants of San Diego, Poway, California, United States, 92064
Retinal Consultants Medical Group Inc, Sacramento, California, United States, 95825
Orange County Retina Medical Group, Santa Ana, California, United States, 92705
Bay Area Retina Associates Walnut Creek, Walnut Creek, California, United States, 94598
Florida Retina Institute- Jacksonville, Jacksonville, Florida, United States, 32216
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
50 Years to
ALL
No
Annexon, Inc.,
Clinical Trials, STUDY_DIRECTOR, Annexon, Inc.
2027-10-31